BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 16289718)

  • 1. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.
    Kim DW; Lim SB; Kim DY; Kim TH; Jung KH; Kim DH; Chang HJ; Sohn DK; Hong CW; Choi HS; Jeong SY; Park JG
    Eur J Surg Oncol; 2006 Mar; 32(2):162-7. PubMed ID: 16289718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis.
    Luna-Pérez P; Rodríguez-Ramírez S; Hernández-Pacheco F; Gutiérrez De La Barrera M; Fernández R; Labastida S
    J Surg Oncol; 2003 Jan; 82(1):3-9. PubMed ID: 12501163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
    Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications after sphincter-saving resection in rectal cancer patients according to whether chemoradiotherapy is performed before or after surgery.
    Kim CW; Kim JH; Yu CS; Shin US; Park JS; Jung KY; Kim TW; Yoon SN; Lim SB; Kim JC
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):156-63. PubMed ID: 20106604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
    Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
    Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
    Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
    Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphincter preservation therapy for rectal cancer.
    Aitken C; Breen E; Mamon HJ
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
    Crane CH; Skibber JM; Feig BW; Vauthey JN; Thames HD; Curley SA; Rodriguez-Bigas MA; Wolff RA; Ellis LM; Delclos ME; Lin EH; Janjan NA
    Cancer; 2003 Jan; 97(2):517-24. PubMed ID: 12518377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal cancer adjuvant chemotherapy: when is more useful?
    Pasetto LM; Basso U; Sinigaglia G; Pucciarelli S; Friso ML; Rugge M; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(3B):1805-12. PubMed ID: 18630464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of long-term follow-up for transanal excision for rectal cancer.
    Gonzalez QH; Heslin MJ; Shore G; Vickers SM; Urist MM; Bland KI
    Am Surg; 2003 Aug; 69(8):675-8; discussion 678. PubMed ID: 12953825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of anal sphincter preservation rate according to tumor level and neoadjuvant chemoradiotherapy in rectal cancer patients.
    Baik SH; Kim NK; Lee KY; Sohn SK; Cho CH
    J Gastrointest Surg; 2008 Jan; 12(1):176-82. PubMed ID: 17694418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Hepatogastroenterology; 2012 Oct; 59(119):2142-6. PubMed ID: 22366527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.
    Vironen J; Juhola M; Kairaluoma M; Jantunen I; Kellokumpu I
    Int J Colorectal Dis; 2005 Sep; 20(5):440-5. PubMed ID: 15856263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saving the sphincter in rectal cancer: are we prepared to change practice?
    Wallace MH; Glynne-Jones R
    Colorectal Dis; 2007 May; 9(4):302-8; discussion 308-9. PubMed ID: 17432980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Pudełko M; Kryj M; Oledzki J; Szmeja J; Słuszniak J; Serkies K; Kładny J; Pamucka M; Kukołowicz P
    Radiother Oncol; 2004 Jul; 72(1):15-24. PubMed ID: 15236870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
    Velenik V; Ocvirk J; Oblak I; Anderluh F
    Eur J Surg Oncol; 2010 Mar; 36(3):244-50. PubMed ID: 20042310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.